Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: A retrospective case-control study

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Erdman, Laura K ^a   Dhabangi, Aggrey ^b   Musoke, Charles ^b   Conroy, Andrea L ^a   Hawkes, Michael ^a   Higgins, Sarah ^a   Rajwans, Nimerta ^a   Wolofsky, Kayla T ^c   Streiner, David L ^d   Liles, W Conrad ^a   Cserti Gazdewich, Christine M ^e   Kain, Kevin C ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOGLIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; VASCULOTROPIN RECEPTOR 1; VON WILLEBRAND FACTOR;

ACCURACY; ARTICLE; BRAIN MALARIA; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA ANEMIA; MALE; PREDICTION; PRESCHOOL CHILD; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; CLASSIFICATION; HOSPITALIZATION; INFANT; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; UGANDA; VALIDATION STUDY;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALARIA; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; UGANDA;

EID: 79952134868     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017440     Document Type: Article

References (54)

1. World Health Organization (2009) World Malaria Report. Geneva, Switzerland. Available: http://whqlibdoc.who.int/publications/2009/9789241563901_eng.pdf. Accessed: 13 May 2010.
2. Murphy SC, Breman JG, (2001) Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg 64: 57-67.
3. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, et al. (1995) Indicators of life-threatening malaria in African children. N Engl J Med 332: 1399-1404.
4. Helbok R, Kendjo E, Issifou S, Lackner P, Newton CR, et al. (2009) The Lambarene Organ Dysfunction Score (LODS) is a simple clinical predictor of fatal malaria in African children. J Infect Dis 200: 1834-1841.
5. van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE, (2006) A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol 22: 503-508.
6. Clark IA, Alleva LM, Mills AC, Cowden WB, (2004) Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev 17: 509-539.
7. Faille D, El-Assaad F, Alessi MC, Fusai T, Combes V, et al. (2009) Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding. Thromb Haemost 102: 1093-1102.
8. Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, et al. (2004) Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 72: 5630-5637.
9. Othoro C, Lal AA, Nahlen B, Koech D, Orago AS, et al. (1999) A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis 179: 279-282.
10. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, et al. (1989) Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 320: 1586-1591.
11. Kurtzhals JA, Adabayeri V, Goka BQ, Akanmori BD, Oliver-Commey JO, et al. (1998) Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351: 1768-1772.
12. Gyan B, Kurtzhals JA, Akanmori BD, Ofori M, Goka BQ, et al. (2002) Elevated levels of nitric oxide and low levels of haptoglobin are associated with severe malarial anaemia in African children. Acta Trop 83: 133-140.
13. Chiwakata CB, Manegold C, Bonicke L, Waase I, Julch C, et al. (2001) Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria. J Infect Dis 183: 1161-1164.
14. Armah HB, Wilson NO, Sarfo BY, Powell MD, Bond VC, et al. (2007) Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J 6: 147.
15. Ford JW, McVicar DW, (2009) TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 21: 38-46.
16. Beare NA, Harding SP, Taylor TE, Lewallen S, Molyneux ME, (2009) Perfusion abnormalities in children with cerebral malaria and malarial retinopathy. J Infect Dis 199: 263-271.
17. Medana IM, Turner GD, (2006) Human cerebral malaria and the blood-brain barrier. Int J Parasitol 36: 555-568.
18. Dietmann A, Helbok R, Lackner P, Fischer M, Reindl M, et al. (2009) Endoglin in African children with Plasmodium falciparum malaria: a novel player in severe malaria pathogenesis? J Infect Dis 200: 1842-1848.
19. Turner GD, Ly VC, Nguyen TH, Tran TH, Nguyen HP, et al. (1998) Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Pathol 152: 1477-1487.
20. Muehlenbachs A, Fried M, Lachowitzer J, Mutabingwa TK, Duffy PE, (2008) Natural selection of FLT1 alleles and their association with malaria resistance in utero. Proc Natl Acad Sci U S A 105: 14488-14491.
21. Lowenstein CJ, Morrell CN, Yamakuchi M, (2005) Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc Med 15: 302-308.
22. Hollestelle MJ, Donkor C, Mantey EA, Chakravorty SJ, Craig A, et al. (2006) von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation. Br J Haematol 133: 562-569.
23. Lovegrove FE, Tangpukdee N, Opoka RO, Lafferty EI, Rajwans N, et al. (2009) Serum angiopoietin-1 and-2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One 4: e4912.
24. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, et al. (2008) Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci U S A 105: 17097-17102.
25. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, et al. (2006) Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 3: e46.
26. Bridges DJ, Bunn J, van Mourik JA, Grau G, Preston RJ, et al. (2010) Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood 115: 1472-1474.
27. Conroy AL, Lafferty EI, Lovegrove FE, Krudsood S, Tangpukdee N, et al. (2009) Whole blood angiopoietin-1 and-2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria. Malar J 8: 295.
28. Opoka RO, Xia Z, Bangirana P, John CC, (2008) Inpatient mortality in children with clinically diagnosed malaria as compared with microscopically confirmed malaria. Pediatr Infect Dis J 27: 319-324.
29. Ministry of Health of Uganda (2006) National Policy on Malaria Treatment. Kampala, Uganda. Available: http://www.health.go.ug/mcp/NationalPolicyonMalariaTreatment(07_03_06).pdf. Accessed: 17 May 2010.
30. DeLong ER, DeLong DM, Clarke-Pearson DL, (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
31. Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD, (2001) Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Making 21: 45-56.
32. Hosmer DW, Lemeshow S, (2000) Applied Logistic Regression. 2nd ed New York John Wiley & Sons, Inc.
33. World Health Organization (2000) Severe falciparum malaria. Trans R Soc Trop Med Hyg 94 (Suppl 1): S1-90.
34. Harrell FE Jr, Lee KL, Mark DB, (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15: 361-387.
35. Morrow DA, Braunwald E, (2003) Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation 108: 250-252.
36. Vinueza CA, Chauhan SP, Barker L, Hendrix NW, Scardo JA, (2000) Predicting the success of a trial of labor with a simple scoring system. J Reprod Med 45: 332-336.
37. Bouchon A, Dietrich J, Colonna M, (2000) Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164: 4991-4995.
38. Gomez-Pina V, Soares-Schanoski A, Rodriguez-Rojas A, Del Fresno C, Garcia F, et al. (2007) Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol 179: 4065-4073.
39. Bouchon A, Facchetti F, Weigand MA, Colonna M, (2001) TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410: 1103-1107.
40. Schenk M, Bouchon A, Seibold F, Mueller C, (2007) TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J Clin Invest 117: 3097-3106.
41. Chimma P, Roussilhon C, Sratongno P, Ruangveerayuth R, Pattanapanyasat K, et al. (2009) A distinct peripheral blood monocyte phenotype is associated with parasite inhibitory activity in acute uncomplicated Plasmodium falciparum malaria. PLoS Pathog 5: e1000631.
42. Shapiro NI, Yano K, Okada H, Fischer C, Howell M, et al. (2008) A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shock 29: 452-457.
43. Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, et al. (2006) Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 203: 1447-1458.
44. Deininger MH, Winkler S, Kremsner PG, Meyermann R, Schluesener HJ, (2003) Angiogenic proteins in brains of patients who died with cerebral malaria. J Neuroimmunol 142: 101-111.
45. Casals-Pascual C, Idro R, Gicheru N, Gwer S, Kitsao B, et al. (2008) High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Proc Natl Acad Sci U S A 105: 2634-2639.
46. Jain V, Armah HB, Tongren JE, Ned RM, Wilson NO, et al. (2008) Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J 7: 83.
47. Tchinda VH, Tadem AD, Tako EA, Tene G, Fogako J, et al. (2007) Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha. Acta Trop 102: 20-28.
48. Greve B, Kremsner PG, Lell B, Luckner D, Schmid D, (2000) Malarial anaemia in African children associated with high oxygen-radical production. Lancet 355: 40-41.
49. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, et al. (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12: 235-239.
50. Raj DS, (2009) Role of interleukin-6 in the anemia of chronic disease. Semin Arthritis Rheum 38: 382-388.
51. Gomei Y, Nakamura Y, Yoshihara H, Hosokawa K, Iwasaki H, et al. (2010) Functional differences between two Tie2 ligands, angiopoietin-1 and-2, in regulation of adult bone marrow hematopoietic stem cells. Exp Hematol 38: 82-89.
52. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, et al. (2007) Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med 204: 2693-2704.
53. Boggild AK, Krudsood S, Patel SN, Serghides L, Tangpukdee N, et al. (2009) Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 49: 841-849.
54. Lee WG, Kim YG, Chung BG, Demirci U, Khademhosseini A, (2009) Nano/Microfluidics for diagnosis of infectious diseases in developing countries. Adv Drug Deliv Rev 62: 449-457.